THE Therapeutic Goods Administration (TGA) has confirmed its decision to upschedule products containing codeine to a prescription only status from over-the-counter (S2/3 to S4) (PD breaking news).
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 20 Dec 16
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Dec 16
